Preparation method and application of fructus rosae laevigatae extract for promoting cell growth factor expression and angiogenesis
Through the extraction of Jinyingzi extract and the separation of macropore adsorption resin D101, the problems of high cost of cell growth factors and angiogenesis and side effects in the existing technology are solved, and the expression of cell growth factors and angiogenesis effects are significantly improved. The treatment of burns and scalds and ischemic diseases provides new Chinese medicine applications.
Patent Information
- Application Number
- CN202411175390.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-26
- Publication Date
- 2024-11-22
AI Technical Summary
The existing technologies for promoting cell growth factors and angiogenesis are costly and have side effects. Research on traditional Chinese medicine in this field has not been fully developed, especially traditional Chinese medicine has insufficient understanding of the mechanism and molecular level of angiogenesis.
The extract of flavonoid extract was separated by extraction and macroporous adsorption resin D101 chromatography column to prepare the extract of flavonoid extract that promotes cell growth factor expression and angiogenesis. The flavonoids, polysaccharides and other components were used to significantly upregulate cell growth factors. Express and promote angiogenesis.
It significantly improves the expression level and number of angiogenesis of cell growth factors in tissues, has potential clinical therapeutic effects, has positive effects on burns, tissue repair and ischemic diseases, and is superior in safety and economics.
Smart Images

Figure CN118987094A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of traditional Chinese medicine technology, and particularly relates to a preparation method and application of a Rosa laevigata extract for promoting cell growth factor expression and angiogenesis. Background Art
[0002] Cell growth factors are a class of active proteins or polypeptide substances that are secreted by a variety of cells and act on specific target cells. They regulate cell division, matrix synthesis, tissue differentiation and other functions by binding to specific, high-affinity cell membrane receptors. There are many types of cell growth factors, which can be mainly divided into platelet growth factors [platelet-derived growth factor (PDGF), osteosarcoma-derived growth factor (ODGF)], epidermal growth factors [epidermal growth factor (EGF), transforming growth factor (TGF-α and TGF-β)], fibroblast growth factor (aFGF and bFGF), insulin-like growth factor (IGF-I and IGF-II), nerve growth factor (NGF), interleukin growth factors (IL-1, IL-1, IL-3, etc.), erythropoietin (EPO), etc. A large number of studies have confirmed that cell growth factors have important functions such as promoting cell growth, differentiation, proliferation and migration, regulating metabolism, etc., and have important regulatory effects on immune function regulation, hematopoietic system regulation, tumor occurrence and development, inflammation and infection, wound repair, tissue reconstruction, etc., and have broad application prospects and potential. Most of the cell growth factors discovered so far can be artificially synthesized or artificially mediated, but the high cost leads to high prices, and improper use and dosage will also produce certain side effects. At present, studies have confirmed that traditional Chinese medicine can promote the secretion of cell growth factors.
[0003] Angiogenesis generally refers to the process of new blood vessels formed from existing capillaries or post-capillary veins in tissues. It occurs under a variety of physiological and pathological conditions, such as growth and development, wound healing, and treatment of ischemic cardiovascular diseases (such as coronary heart disease). The angiogenesis process is complex and involves the regulatory effects of multiple cytokines and growth factors, such as vascular endothelial growth factor (VEGF), which can directly stimulate the movement, proliferation and division of endothelial cells and increase vascular permeability; basic fibroblast growth factor (bFGF), which can promote the proliferation and migration of endothelial cells. Therapeutic angiogenesis therapy is a treatment method that promotes angiogenesis in ischemic tissues by regulating the level of vascular growth factors. This therapy has attracted widespread attention in the medical community at home and abroad and has shown great potential in clinical treatment. In recent years, traditional Chinese medicine has made significant progress in this field. For example, Musk Heart Pills have been proven to promote angiogenesis in ischemic myocardium. It can promote blood vessel formation and improve myocardial blood supply by regulating and increasing the expression of angiogenic factors such as VEGF and FGF.
[0004] Rosa laevigataRosa laevigata Michx.) is a plant of the genus Rosa in the Rosaceae family. Its aliases include prickly elm and sugar jar. It is distributed in North China, South China and other regions. As a commonly used Chinese medicine, its flowers, leaves, roots and fruits can all be used as medicine. It is recorded in the Compendium of Materia Medica: "Fructus Rosae Laevigatae is sour, astringent, flat in nature, non-toxic, and mainly treats diarrhea and dysentery, stops urination, and astringes the essence and qi; taking it for a long time can make people resistant to cold and lighten the body, and replenish blood and essence, with miraculous effects". Modern pharmacological studies have shown that the flavonoids, polysaccharides and other ingredients contained in Fructus Rosae Laevigatae have anti-inflammatory, antibacterial and antioxidant effects. Based on the efficacy research of Chinese medicine, the present invention has found the previously unreported effect of Fructus Rosae Laevigatae in promoting the expression of cell growth factors and angiogenesis, and has potential positive effects on the clinical treatment and application of burns, tissue repair, ischemic diseases and other problems. Summary of the invention
[0005] The purpose of the present invention is to provide a preparation method and application of a Rosa laevigata extract for promoting cell growth factor expression and angiogenesis.
[0006] To achieve the above object, the present invention adopts the following technical solution: A method for preparing a Rosa laevigata extract for promoting cell growth factor expression and angiogenesis is carried out according to the following steps: S1: taking dried Rosa laevigata fruit, crushing it, adding distilled water to extract, and obtaining an extract; filtering the obtained extract, and concentrating the filtrate by rotary evaporation to obtain a concentrate 1; vacuum freeze-drying the obtained concentrate 1 to obtain a freeze-dried powder 1, and storing it at -20°C for later use; S2: Dissolve the lyophilized powder 1 obtained in step S1 with deionized water, load it onto a macroporous adsorption resin D101 chromatography column, let it stand for binding after adsorption, elute with distilled water, and collect the eluate; concentrate the obtained eluate by rotary evaporation to obtain a concentrated solution 2; freeze-dry the obtained concentrated solution 2 in a vacuum to obtain a lyophilized powder 2, which is a Rosa laevigata extract that promotes cell growth factor expression and angiogenesis, and store it at -20°C for future use; In step S1, the extraction conditions are: the mass ratio of Rosa laevigata fruit to distilled water is 1:10, and the extraction is carried out at 4° C. overnight; In step S1, the rotary evaporation concentration conditions are: rotation speed 100 rpm, temperature 55° C., and concentration to 5% of the original volume; In step S1, the vacuum freeze-drying conditions are: temperature -50°C, pressure 50Pa, time 48h; In step S2, the adsorption and elution conditions are as follows: the freeze-dried powder 1 is dissolved in deionized water at a mass ratio of 2:10, the sample is loaded at a flow rate of 0.5 mL / min, and the sample is eluted with distilled water at an elution flow rate of 2 mL / min, and the elution volume is 3 times the amount of the resin; In step S2, the rotary evaporation concentration conditions are: rotation speed 100 rpm, temperature 55° C., and concentration to 5% of the original volume; In step S2, the vacuum freeze-drying conditions are: temperature -50°C, pressure 50Pa, and time 48h.
[0007] A Rosa laevigata extract prepared by the preparation method.
[0008] The application of the above-mentioned Rosa Laevigata extract is any one or more of the following: 1) Application in the preparation of drugs for promoting the expression of cell growth factors; 2) Application in the preparation of drugs for promoting angiogenesis; 3) Application in the preparation of drugs for treating wounds; The cell growth factors include vascular endothelial growth factor A, epidermal growth factor, keratinocyte growth factor and basic fibroblast growth factor; The blood vessels include wound surface blood vessels; The wounds include burns, scalds, post-traumatic wounds, post-war wounds, diabetic wounds, wounds caused by chemotherapy and radiotherapy, post-transplantation wounds, wounds caused by vascular diseases, bedsores and frostbite.
[0009] The significant advantages of the present invention are: 1) Macroporous adsorption resin D101 is a non-polar macroporous adsorption resin with advantages such as high specific surface area, high adsorption capacity, good mechanical strength, long service life, good anti-organic pollution effect, and easy regeneration. It is suitable for selective adsorption of non-polar organic molecules, especially in the field of plant extraction. It has significant effects on the adsorption and separation of effective components such as saponins, flavonoids, and polyphenols, and does not adsorb hydrophilic organic substances such as sugars, proteins, amino acids, and inorganic acids. Considering that hydrophilic components have significant advantages in drug development, such as high solubility, biocompatibility, stability, low toxicity and economy, the present invention adopts an extraction method to prepare the water extract of Rosa laevigata, and separates the hydrophilic components such as sugars and amino acids therein by macroporous adsorption resin D101, and obtains a Rosa laevigata extract that can upregulate the expression of multiple cell growth factors at the tissue level and promote angiogenesis, which has a positive role in the clinical treatment and application of burns, tissue repair, ischemic diseases and other problems and is the first discovery.
[0010] 2) Epidermal growth factor (EGF) has the functions of promoting the proliferation of epidermal cells, epithelial cells, fibroblasts, enhancing the vitality of epidermal cells, delaying the aging of epidermal cells, etc. It is often used in skin wound repair and promoting the epithelialization of granulation tissue. Keratinocyte growth factor (KGF) has the effects of promoting the proliferation and differentiation of epithelial cells and promoting wound healing. Vascular endothelial growth factor (VEGFA) is a highly specific endothelial cell growth factor that promotes increased vascular permeability, endothelial cell migration and proliferation, and angiogenesis. Basic fibroblast growth factor (bFGF) has the functions of promoting the division and proliferation of various cells derived from the mesoderm and neuroectoderm, such as endothelial cells, epithelial cells and glial cells, promoting angiogenesis, wound healing and tissue repair, and participating in nerve regeneration. Animal experiments confirmed that the Rosa laevigata extract prepared by the present invention can significantly upregulate the expression levels of the above-mentioned cell growth factors in tissues. After administration of 20 mg / kg / d and 80 mg / kg / d for 7 days, the expression levels of EGF can reach 9.4 times and 15.4 times of that of the control, respectively; the expression levels of KGF can reach 5.2 times and 9.7 times of that of the control, respectively; the expression levels of VEGFA can reach 2.3 times and 2.8 times of that of the control, respectively; and the expression levels of bFGF can reach 2.8 times and 3.9 times of that of the control, respectively.
[0011] 3) "Angiogenesis" refers to the process of forming new blood vessels from the pre-existing vascular system after chemical and mechanical stimulation. This process is crucial for many physiological (embryo development, ovulation, wound healing) and pathological events (tumor growth, arthritis, diabetic retinopathy). Traditional Chinese medicine promotes angiogenesis from the aspects of reducing endothelial cell damage, promoting endothelial cell proliferation, and tube formation. However, the research on the mechanism of action of traditional Chinese medicine in promoting angiogenesis involves less molecular level, and the regulation of angiogenesis by traditional Chinese medicine monomers and compound prescriptions is bidirectional, which can promote angiogenesis and inhibit angiogenesis. Therefore, it is still necessary to determine its safe dose and dosage form through basic experiments. Animal experiments confirmed that the extract of the golden cherry prepared by the present invention can significantly increase the number of new blood vessels in the skin wound of mice. After administration of 20 mg / kg / d for 7d and 14d, the number of new blood vessels in the wound can reach 3.3 times and 6.0 times that of the control, respectively; after administration of 80 mg / kg / d for 7d and 14d, the number of new blood vessels in the wound can reach 6.3 times and 3.8 times that of the control, respectively. BRIEF DESCRIPTION OF THE DRAWINGS
[0012] Figure 1 :Effect of Rosa Laevigata Extract on the Expression of Cell Growth Factors. Compared with the blank group,*** P <0.001, indicating a significant difference.
[0013] Figure 2:Effect of Rosa Laevigata Extract on Angiogenesis. The red arrows point to the new blood vessels; compared with the blank group, ** P <0.01,* P <0.05, indicating a significant difference.
[0014] Note: CON means blank group. DETAILED DESCRIPTION
[0015] In order to make the contents of the present invention easier to understand, the technical solution of the present invention is further described below in conjunction with specific implementation methods, but the present invention is not limited thereto.
[0016] Embodiment 1: A method for preparing a Rosa laevigata extract for promoting cell growth factor expression and angiogenesis is carried out according to the following steps: S1: Crush the dried Rosa laevigata fruit, add distilled water at a solid-liquid ratio of 1:10 (g / mL), stir evenly, and soak overnight at 4°C to obtain an extract; filter the extract, and concentrate the filtrate by rotary evaporation at a speed of 100 rpm and a temperature of 55°C to 5% of the original volume to obtain a concentrated solution 1; vacuum freeze-dry the concentrated solution 1 at a temperature of -50°C and 50 Pa for 48 hours to obtain a freeze-dried powder 1, which is stored at -20°C for later use.
[0017] S2: Take 100g of macroporous adsorption resin D101, soak it in anhydrous ethanol for 24h to fully swell, pour out the ethanol and floating materials, load the resin into a glass chromatography column (length 30cm, inner diameter 2cm), rinse it repeatedly with anhydrous ethanol until the eluent and distilled water are mixed in equal volumes without white turbidity, then balance the column with distilled water until the resin is evenly arranged, there are no bubbles, and the eluent has no alcohol taste, then add absorbent cotton on the top of the resin to obtain the macroporous adsorption resin D101 chromatography column for use. Take 2 g of freeze-dried powder 1 and dissolve it in 10 mL of deionized water, then load it onto a macroporous adsorption resin D101 chromatography column at a loading flow rate of 0.5 mL / min. After adsorption, let it stand for 30 minutes, then elute it with 3 times the amount of resin (i.e. 300 mL) of distilled water at an elution flow rate of 2 mL / min, and collect the eluate; concentrate the eluate by rotary evaporation at a speed of 100 rpm and a temperature of 55°C to 5% of the original volume to obtain a concentrated solution 2; vacuum freeze-dry the concentrated solution 2 at a temperature of -50°C and 50 Pa for 48 hours to obtain a freeze-dried powder 2, which is a Rosa laevigata extract that promotes cell growth factor expression and angiogenesis, and store it at -20°C for future use.
[0018] Example 2: Effect of Rosa Laevigata Extract on Cell Growth Factor Expression The Rosa laevigata extract was prepared according to the method of Example 1.
[0019] After 3 days of adaptive feeding, C57BL / 6 mice were randomly divided into a blank group and a Rosa laevigata group. All mice were anesthetized by intraperitoneal injection of 20% urethane, and the hair on the back of the mice was shaved. A 1 cm × 1 cm full-thickness skin excision wound was made in the middle of the dorsal spine of each mouse using a skin biopsy device and scissors. After modeling, the blank group was only treated with normal saline, and the Rosa laevigata group mice were treated with low-concentration (20 mg / kg / d) and high-concentration (80 mg / kg / d) Rosa laevigata extracts to apply to the wound. Both groups were treated for 14 days (once a day). Some mice in each group were killed on the 7th day after surgery, and the skin tissue near the wound was obtained. After lysis and centrifugation, the total protein extract was obtained and the protein concentration was determined. Protein electrophoresis was performed by SDS-PAGE, and the protein was transferred to a PVDF membrane at a constant voltage of 100V for 1h. The PVDF membrane was placed in TBST blocking solution containing 5% BSA and blocked at room temperature for 1 hour, and then the primary antibody (1:3000) of cell growth factors such as VEGFA was added and incubated at 4°C overnight. After washing three times with TBST, the secondary antibody (1:5000) was added and incubated at room temperature for 1 hour. After washing three times with TBST, ECL luminescent solution was added, and the ChemiDoc XRS+ system was used for imaging to detect the expression level of cell growth factors such as VEGFA in the skin tissue near the wound.
[0020] The experimental results are shown in Figure 1 Compared with the blank group, low-concentration and high-concentration Rosa laevigata extracts could significantly upregulate the expression levels of cell growth factors such as VEGFA, EFG, KGF and bFGF in the skin tissue near the wound on the 7th day.
[0021] Example 3: Effect of Rosa Laevigata Extract on Angiogenesis The Rosa laevigata extract was prepared according to the method of Example 1.
[0022] After 3 days of adaptive feeding, C57BL / 6 mice were randomly divided into a blank group and a Rosa laevigata group. All mice were anesthetized by intraperitoneal injection (20% urethane), and the hair on the back of the mice was shaved. A 1 cm × 1 cm full-thickness skin excision wound was made in the middle of the dorsal spine of each mouse using a skin biopsy device and scissors. After modeling, the blank group was only treated with normal saline, and the Rosa laevigata group mice were treated with low-concentration (20 mg / kg / d) and high-concentration (80 mg / kg / d) Rosa laevigata extracts to apply to the wound. Both groups were treated for 14 consecutive days (once / d). Some mice in each group were killed on the 7th and 14th days after surgery, and the skin tissue near the wound was taken for H&E staining analysis to observe the angiogenesis of the mouse skin wound.
[0023] The experimental results are shown in Figure 2 Compared with the blank group, low-concentration and high-concentration Rosa laevigata extracts could significantly increase the number of new blood vessels in the skin wound of mice on the 7th and 14th days.
[0024] The above description is only a preferred embodiment of the present invention. All equivalent changes and modifications made according to the scope of the patent application of the present invention should fall within the scope of the present invention.
Claims
1. A method for preparing a Rosa laevigata extract that promotes cell growth factor expression and angiogenesis, characterized in that: Follow these steps: S1: taking dried Rosa laevigata fruit, crushing it, adding distilled water to extract, and obtaining an extract; filtering the obtained extract, and concentrating the filtrate by rotary evaporation to obtain a concentrate 1; vacuum freeze-drying the obtained concentrate 1 to obtain a freeze-dried powder 1, and storing it at -20°C for later use; S2: Dissolve the lyophilized powder 1 obtained in step S1 with deionized water, load it on a macroporous adsorption resin D101 chromatography column, let it stand to combine after adsorption, elute with distilled water, and collect the eluate; concentrate the obtained eluate by rotary evaporation to obtain a concentrated solution 2; vacuum freeze-dry the obtained concentrated solution 2 to obtain a lyophilized powder 2, which is a Rosa laevigata extract that promotes cell growth factor expression and angiogenesis, and store it at -20°C for future use.
2. The preparation method according to claim 1, characterized in that: In step S1, the extraction conditions are: the mass ratio of Rosa laevigata fruit to distilled water is 1:10, and the extraction is carried out at 4° C. overnight.
3. The preparation method according to claim 1, characterized in that: In step S1, the rotary evaporation concentration conditions are: rotation speed 100 rpm, temperature 55° C., and concentration to 5% of the original volume.
4. The preparation method according to claim 1, characterized in that: In step S1, the vacuum freeze-drying conditions are: temperature -50°C, pressure 50Pa, and time 48h.
5. The preparation method according to claim 1, characterized in that: In step S2, the adsorption and elution conditions are as follows: the freeze-dried powder 1 is dissolved in deionized water at a mass ratio of 2:10, loaded at a flow rate of 0.5 mL / min, eluted with distilled water, the elution flow rate is 2 mL / min, and the elution volume is 3 times the amount of resin.
6. The preparation method according to claim 1, characterized in that: In step S2, the rotary evaporation concentration conditions are: rotation speed 100 rpm, temperature 55° C., and concentration to 5% of the original volume.
7. The preparation method according to claim 1, characterized in that: In step S2, the vacuum freeze-drying conditions are: temperature -50°C, pressure 50Pa, and time 48h.
8. A Rosa Laevigata extract prepared by the preparation method according to any one of claims 1 to 7.
9. The use of the Rosa Laevigata extract according to claim 8, characterized in that: Any one or more of the following: 1) Application in the preparation of drugs for promoting the expression of cell growth factors; 2) Application in the preparation of drugs for promoting angiogenesis; 3) Application in the preparation of medicines for treating wounds.
10. The use according to claim 9, characterized in that: The cell growth factors include vascular endothelial growth factor A, epidermal growth factor, keratinocyte growth factor and basic fibroblast growth factor; the blood vessels include wound blood vessels; the wounds include burns, scalds, post-traumatic wounds, post-war wounds, diabetic wounds, wounds caused by chemotherapy, radiotherapy, post-transplantation wounds, wounds caused by vascular diseases, bedsores and frostbite.
Citation Information
Patent Citations
Technique of extracting polysaccharide in rosa laevigata michx
CN101036711A
Application of fructus rosae laevigatae or fructus rosae laevigatae aqueous extract in preparation of medicine for promoting skin wound repair
CN115350217A
Burn treating cream
CN1569111A
